Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

AR-42 displays potent antitumor effects in models of embryonal carcinoma

Feb. 25, 2011

Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe

Feb. 24, 2011

Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer

Feb. 24, 2011

PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC

Feb. 24, 2011

Gelsolin is a putative biomarker in subarachnoid hemorrhage

Feb. 23, 2011

IST5-002 shows promise in models of prostate cancer

Feb. 23, 2011

Phase I/II trial of panobinostat/bicalutamide combination in prostate cancer advances

Feb. 23, 2011

Tasquinimod improves PFS in phase II trial in metastatic CRPC

Feb. 22, 2011

Promising phase II data on cabozantinib in patients with prostate cancer and soft tissue disease

Feb. 22, 2011

Initial doses of TRC-105 are tolerated in patients with castration-resistant prostate cancer

Feb. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...